Recent reports on the discovery and antistaphylococcal specificity of lysostaphin , on its purification (Shindler and Schuhardt, 1965) , on its utility against a large number of clinical strains of Staphylococcus aureus both in vitro Cropp and Harrison, 1964; Harrison and Cropp, 1965) and in vivo , and on its enzymatic mode of action (Browder et al., Biochem. Biophys. Res. Commun., in press) have delineated some of the major features of this unique antibiotic. In contrast to the penicillins, which exert their effect by suppressing cell-wall synthesis, lysostaphin is effective by virtue of its ability to cleave the staphylococcal cell wall, without distinguishing between staphylococcal cells that produce penicillinase and those that do not, or among staphylococcal cells of different phage susceptibility.
In view of the prominence of penicillins in the chemotherapy of staphylococcal infections, it seemed pertinent to extend our earlier comparisons of lysostaphin with benzylpenicillin, ampicillin, and dimethoxypenicillin (Harrison and Cropp, 1965) Table 1 shows the MIC values observed against the 20 strains of S. aureus tested. All of the strains are resistant to penicillin G, ampicillin, and propicillin and, hence, are penicillinase producers. The Haight and Finland tests for penicillinase production verified this conclusion. The main advantage of propicillin is associated with its enhanced activity over benzylpenicillin against certain gram-negative bacteria. Klein and Finland (1963) reported, however, that neither of these penicillins has any significant biological activity against penicillinase-producing staphylococci.
The efficacy of the penicillinase-insensitive penicillins in inhibiting the growth of these cultures varied within a 15-fold range in concentrations, 0.20 to 3.12 ,ug/ml. 30, 000 for the enzyme, lysostaphin), the above ratios increase further by an additional factor of about 75 (resulting in a final ratio of 300-to 600-fold in favor of lysostaphin).
Additional studies are in progress to delineate more fully the role of this antibiotic in staphylococcal disease.
